Home Finance Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says

Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says

43
0

Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says


A coldbox containing monoclonal antibody treatments at a Regeneron clinic in Pembroke Pines, Fla., earlier this year.

Photo: Eva Marie Uzcategui/Bloomberg News

Published at Mon, 08 Nov 2021 15:31:00 +0000

https://www.wsj.com/articles/regenerons-antibody-drug-cut-risk-of-covid-19-by-82-company-says-11636385459?mod=pls_whats_news_us_business_f

Previous articleThe Archbishop Has Spoken
Next article22 Stylish Gifts That Will Totally Wow Any Fashion Girl